Clinical Trial Update: A Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or Overweight [Phase 2]

View source ↗

Summary

A Phase 2b clinical trial update for MET097 evaluating efficacy and safety in adults with obesity or overweight; the study is currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• MET097

Snippet

Sponsor: Metsera, a wholly owned subsidiary of Pfizer | Conditions: Obesity, Overweight or Obesity | Phase 2 | Status: ACTIVE_NOT_RECRUITING